Search results for: 'nanoparticles pharma'

•The sensors market is expanding, and it is regarded as one of the most promising areas in the semiconductor industry. Sensor technology is an evolving discipline that holds the potential to significantly improve the performance, durability, maintenance, and applicability of many engineering projects. Material science and engineering advancements h...

This edition of the Oil and Gas (O&G) TOE features information about the conversion of natural gas into high-quality liquid derivatives using gas-to-liquid (GTL) technology. The TOE also covers the innovations in drone technology for monitoring midstream and upstream assets. The TOE focuses on real-time data management technologies to enhance drill...

This issue of the Nanotechnology Opportunity Engine profiles significant advances in nanotechnology for various industrial applications. The featured innovations include Contemporary Graphene Production for Advanced Material Applications, Low-Waste Nano-Oxide Manufacturing for Battery and High-Purity Applications, Visible-Light Activated Antimicrob...

This edition of the Advanced Coating & Surface Technology Opportunity Engine profiles significant advances in advanced coatings and surface treatments for various industrial applications. The featured innovations include Hydrogen Barrier Coatings for Next-generation Infrastructure Integrity, Advanced Polymer Coatings for Industrial Asset Protection...

20 Nov 2017  |  North America  |  Market Research

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

Infographics

×

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

This issue of the Nanotechnology Opportunity Engine profiles significant advancements in nanotechnology for various enhanced industrial applications. The featured innovations include Ceramic Nanocoating for Improved Surface Protection Applications, Anti-Stick Nanocoatings for Multi-Industrial Usage, Nanoceramic Composites as a Replacement for Portl...

Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules, cell and gene therapies (CGT), and mRNA therapies, it is imperative for pharma sponsors to pursue partnerships to gain technology access, database generation and analysis, and pre-clinical and clinical research. Furt...